Long term outcomes of transcutaneous non-image guided bleomycin sclerotherapy in orbital/adnexal lymphatic malformations: a protocol-based management in 69 eyes.

Tarjani Vivek DaveBejjanki Kavya MadhuriSrujana LaghmisettyDevjyoti TripathySrikanta Kumar PadhySuryasnata RathSamir MohapatraAkruti DesaiAnasua Ganguly Kapoor

Published in: Eye (London, England) (2021)

Seventy-nine percent of eyes with OA-LM showed a good outcome with transcutaneous and/or transconjunctival non-image guided bleomycin sclerotherapy with no serious adverse events. The results were promising over long-term follow-up.

Keyphrases

optical coherence tomography
pulmonary fibrosis
randomized controlled trial
lymph node
cataract surgery
knee osteoarthritis